More European countries, fully or partially, have suspended the use of the Oxford-AstraZeneca COVID-19 vaccine following reports of several suspected deaths from clotting after vaccinations. But the EU claimed that there is "no indication" that the vaccine is linked to these conditions.
A dose of AstraZeneca COVID-19 vaccine is displayed during the launch of the COVID-19 vaccination campaign at Mulago Specialized Women and Neonatal Hospital in Kampala, Uganda, March 10, 2021. (Photo by Joseph Kiggundu/Xinhua)
